M C Petti
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
Papers in
-
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 2
-
- Retinoids in leukemia and cellular processes 3
- Co-authors
- Franco Mandelli (9 shared papers)Sergio Amadori (5 shared papers)Giovanna Meloni (4 shared papers)Bruno Monarca (2 shared papers)A. M. Testi (2 shared papers)William Arcese (1 shared paper)G Isacchi (1 shared paper)Giuseppe Avvisati (3 shared papers)
In The Last Decade
M C Petti
10 papers receiving 561 citations
Peers
Comparison fields: 5 of 49
- Hematology 365
- Biochemistry 33
- Genetics 55
- Internal Medicine 16
- Infectious Diseases 88
Countries citing papers authored by M C Petti
This map shows the geographic impact of M C Petti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M C Petti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M C Petti more than expected).
Fields of papers citing papers by M C Petti
This network shows the impact of papers produced by M C Petti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M C Petti. The network helps show where M C Petti may publish in the future.
Co-authors
The 25 scholars most cited alongside M C Petti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 142 | |
| 2 | 2009 | 131 | |
| 3 | 1990 | 102 | |
| 4 | 2006 | 90 | |
| 5 | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | 1996 | 55 |
| 6 | 1984 | 28 | |
| 7 | Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemia. | 1989 | 18 |
| 8 | A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia. | 1996 | 13 |
| 9 | Intensification in post-remission treatment of adult acute non lymphocytic leukemia. | 1990 | 2 |
| 10 | 2005 | 1 |
About M C Petti
M C Petti is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Ophthalmology and Infectious Diseases, having authored 10 papers that have together received 582 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (3 papers), Retinoids in leukemia and cellular processes (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Drug-Induced Ocular Toxicity (1 paper), Retinal Diseases and Treatments (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and CNS Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (365 citations), Biochemistry (33 citations), Genetics (55 citations), Internal Medicine (16 citations) and Infectious Diseases (88 citations). M C Petti has collaborated with scholars based in Italy and France. Frequent co-authors include Franco Mandelli, Sergio Amadori, Giovanna Meloni, Bruno Monarca, A. M. Testi, William Arcese, G Isacchi, Giuseppe Avvisati, Roel Willemze and Vito L. Burgio. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Infectious Diseases, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.